ODI Pharma is a producer and supplier of medical cannabis products. The business is run through subsidiaries and partners where sales go through wholesale distributors and pharmacies. The products are used for the treatment of multiple sclerosis, chronic pain, and chemotherapy. ODI Pharma operates in the European market and is headquartered in Stockholm.
CEO
Chairperson of the Board
Board
| Name | Capital % | Votes % | Date |
|---|---|---|---|
| Volker Wiederrich | 39,79 | 39,79 | 2024-09-26 |
| Niclas Kappelin | 26,19 | 26,19 | 2024-09-26 |
| Derek Simmross | 25,95 | 25,95 | 2024-09-26 |
| Tomi Kalevi Heikkinen | 0,33 | 0,33 | 2024-09-26 |
| Siv Merethe Skorpen | 0,32 | 0,32 | 2024-09-26 |
| Erlend Skorpen | 0,27 | 0,27 | 2024-09-26 |
| Nordnet Pensionsförsäkring | 0,19 | 0,19 | 2024-09-26 |
| Christer Wiberg | 0,17 | 0,17 | 2024-09-26 |
| Per Herseth | 0,16 | 0,16 | 2024-09-26 |
| Nordnet Livsforsikring AS | 0,16 | 0,16 | 2024-09-26 |
2024-11-28 Delårsrapport 2025-Q1
